Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure

Physiological Genomics - Tập 27 Số 2 - Trang 156-170 - 2006
Stephan Schiekofer1, Ichiro Shiojima2, Kaori Sato2, Gennaro Galasso2, Yuichi Oshima2, Kenneth Walsh2
1Molecular Cardiology/Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
2Molecular Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts

Tóm tắt

To investigate molecular mechanisms involved in the development of cardiac hypertrophy and heart failure, we developed a tetracycline-regulated transgenic system to conditionally switch a constitutively active form of the Akt1 protein kinase on or off in the adult heart. Short-term activation (2 wk) of Akt1 resulted in completely reversible hypertrophy with maintained contractility. In contrast, chronic Akt1 activation (6 wk) induced extensive cardiac hypertrophy, severe contractile dysfunction, and massive interstitial fibrosis. The focus of this study was to create a transcript expression profile of the heart as it undergoes reversible Akt1-mediated hypertrophy and during the transition from compensated hypertrophy to heart failure. Heart tissue was analyzed before transgene induction, 2 wk after transgene induction, 2 wk of transgene induction followed by 2 days of repression, 6 wk after transgene induction, and 6 wk of transgene induction followed by 2 wk of repression. Acute overexpression of Akt1 (2 wk) leads to changes in the expression of 826 transcripts relative to noninduced hearts, whereas chronic induction (6 wk) led to changes in the expression of 1,611, of which 65% represented transcripts that were regulated during the pathological phase of heart growth. Another set of genes identified was uniquely regulated during heart regression but not growth, indicating that nonoverlapping transcription programs participate in the processes of cardiac hypertrophy and atrophy. These data define the gene regulatory programs downstream of Akt that control heart size and contribute to the transition from compensatory hypertrophy to heart failure.

Từ khóa


Tài liệu tham khảo

10.1074/jbc.274.29.20281

Benjamini Y and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Statistical Soc B 57: 289–300, 1995.

10.1152/physiolgenomics.00087.2003

10.1073/pnas.0436564100

10.1161/01.RES.75.1.23

10.1016/S0959-4388(00)00211-7

10.1016/j.yjmcc.2004.06.020

10.1152/physiolgenomics.00022.2003

10.1073/pnas.172376399

10.1074/jbc.M201462200

10.1161/CIRCULATIONAHA.105.595231

10.1172/JCI24178

10.1074/jbc.273.49.32377

10.1172/JCI24569

10.1073/pnas.100127897

10.1161/01.CIR.101.6.660

10.1038/21218

10.1038/nm0405-367

10.1096/fj.05-5211com

10.1161/01.CIR.103.5.670

10.1161/01.CIR.96.12.4146

10.1152/physiolgenomics.00122.2001

10.1161/01.HYP.0000215207.54689.31

10.1016/j.carpath.2005.03.003

10.1096/fj.04-2841fje

10.1084/jem.192.5.729

10.1152/ajpcell.00058.2005

10.1152/physiolgenomics.00052.2001

10.1161/01.HYP.0000215283.53943.39

10.1172/JCI9419

10.1074/jbc.M200347200

10.1161/01.CIR.104.3.330

10.1006/jmcc.2000.1283

10.1074/jbc.275.7.4693

10.1172/JCI25900

10.1038/43466

10.1016/j.tcm.2004.08.001

10.1074/jbc.275.15.10761

10.1038/43474

10.1016/S0092-8674(04)00400-3

10.1007/s001090050182

10.1161/01.ATV.0000171994.89106.ca

10.1152/japplphysiol.00770.2003

10.1016/j.yjmcc.2004.12.016

10.1128/MCB.22.8.2799-2809.2002

10.1172/JCI24682

10.1074/jbc.M204572200

10.1161/01.RES.0000124394.01180.BE

10.1074/jbc.M500528200

10.1152/ajpheart.00707.2002

10.1161/hh1301.092506

10.1128/MCB.22.13.4803-4814.2002

10.1161/01.RES.0000134920.10128.b4

10.1016/j.yjmcc.2004.12.002

10.1006/jmcc.2002.2068

10.1161/CIRCULATIONAHA.106.615138

10.1172/JCI17664

10.1161/01.RES.0000109415.17511.18

10.1161/01.RES.0000093984.48643.D7

10.1161/01.CIR.102.25.3046

10.1042/bst0320350

10.1016/j.ygeno.2003.08.007

10.1152/physiolgenomics.00040.2004